Microsome biocolloids for rapid drug metabolism and inhibition assessment by LC-MS.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Drug Metabolism Letters

• Publication date

  2008-07-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/187231208785425854PMID 19356087PMCID PMC3473178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enzyme-DNA biocolloids for DNA adduct and reactive metabolite detection by chromatography-mass spectrometry.

  2008cited by this paper
• Genotoxicity screening for N-nitroso compounds. Electrochemical and electrochemiluminescent detection of human enzyme-generated DNA damage from N-nitrosopyrrolidine.

  2007cited by this paper
• Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites.

  2007cited by this paper
• Toxicity screening using biosensors that measure DNA damage.

  2007cited by this paper
• Cytochrome P450 (CYP) inhibition screening: comparison of three tests.

  2006cited by this paper
• Genotoxicity screening using biocatalyst/DNA films and capillary LC-MS/MS.

  2006cited by this paper
• IN SILICO AND IN VITRO SCREENING FOR INHIBITION OF CYTOCHROME P450 CYP3A4 BY COMEDICATIONS COMMONLY USED BY PATIENTS WITH CANCER

  2006cited by this paper
• Cytochrome P450s and other enzymes in drug metabolism and toxicity

  2006cited by this paper
• Elucidating mechanisms of drug-induced toxicity

  2005cited by this paper
• Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity

  2005cited by this paper
• Improving the decision-making process in structural modification of drug candidates: reducing toxicity.

  2004cited by this paper
• Preferential metabolic activation of N-nitrosopiperidine as compared to its structural homologue N-nitrosopyrrolidine by rat nasal mucosal microsomes.

  2003cited by this paper
• Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens.

  2003cited by this paper
• Tobacco carcinogens, their biomarkers and tobacco-induced cancer

  2003cited by this paper
• Nature Reviews Cancer

  2003cited by this paper
• Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.

  2003cited by this paper
• Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.

  2002cited by this paper
• High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.

  2001cited by this paper
• A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.

  2001cited by this paper
• High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites.

  2000cited by this paper
• Determination of a 'GW cocktail' of cytochrome P450 probe substrates and their metabolites in plasma and urine using automated solid phase extraction and fast gradient liquid chromatography tandem mass spectrometry.

  1999cited by this paper
• High-throughput bioanalytical LC/MS/MS determination of benzodiazepines in human urine: 1000 samples per 12 hours.

  1999cited by this paper
• Protein Architecture: Interfacing Molecular Assemblies and Immobilization Biotechnology

  1999cited by this paper
• High throughput liquid chromatography/mass spectrometry bioanalysis using 96-well disk solid phase extraction plate for the sample preparation.

  1998cited by this paper
• High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli.

  1998cited by this paper
• Validation of the five‐drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug‐metabolizing enzymes

  1997cited by this paper
• Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.

  1997cited by this paper
• Cytochrome P450

  1993cited by this paper
• A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans.

  1990cited by this paper
• Carcinogenesis

  1961cited by this paper

• Linking Nanoscale Film Properties to Electrochemical Response in Cytochrome P450 Membrane Enzyme Films

  2025cites this paper
• Evaluation of the effect of Bovis Calculus Artifactus on eight rat liver cytochrome P450 isozymes using LC-MS/MS and cocktail approach

  2021cites this paper
• Roughened graphite biointerfaced with P450 liver microsomes: Surface and electrochemical characterizations.

  2020cites this paper
• Organ-Specific Screening for Protein Damage Using Magnetic Bead Bioreactors and LC-MS/MS.

  2020cites this paper
• Improved electrocatalytic metabolite production and drug biosensing by human liver microsomes immobilized on amine-functionalized magnetic nanoparticles

  2018cites this paper
• Microfluidic array for simultaneous detection of DNA oxidation and DNA-adduct damage.

  2016cites this paper
• Electrochemically Activated Catalytic Pathways of Human Metabolic Cytochrome P450s in Ultrathin Films

  2016cites this paper
• State-of-the-Art Metabolic Toxicity Screening and Pathway Evaluation.

  2016cites this paper
• Elucidating organ-specific metabolic toxicity chemistry from electrochemiluminescent enzyme/DNA arrays and bioreactor bead-LC-MS/MS

  2015cites this paper
• Thin multicomponent films for functional enzyme devices and bioreactor particles.

  2014cites this paper
• Thin Iron Heme Enzyme Films on Electrodes and Nanoparticles for Biocatalysis

  2013cites this paper
• High‐Throughput Enzyme Biocolloid Systems for Drug Metabolism and Genotoxicity Profiling Using LC–MS/MS

  2013cites this paper
• High-throughput metabolic genotoxicity screening with a fluidic microwell chip and electrochemiluminescence.

  2013cites this paper
• Metabolic toxicity screening using electrochemiluminescence arrays coupled with enzyme-DNA biocolloid reactors and liquid chromatography-mass spectrometry.

  2012cites this paper
• Microfluidic electrochemical array for detection of reactive metabolites formed by cytochrome P450 enzymes.

  2011cites this paper
• Efficient bioelectronic actuation of the natural catalytic pathway of human metabolic cytochrome P450s.

  2011cites this paper
• High-throughput metabolic toxicity screening using magnetic biocolloid reactors and LC-MS/MS.

  2010cites this paper
• Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors.

  2009cites this paper
• Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors.

  2009cites this paper
• Comparison of DNA-Reactive Metabolites from Nitrosamine and Styrene Using Voltammetric DNA/Microsomes Sensors.

  2009cites this paper
• Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format.

  2009cites this paper